| 英文名稱 | Laduviglusib | CHIR-99021 | CT99021 |
|---|---|
| 中文名稱 | 拉格魯西布 |
| CAS號 | 252917-06-9 |
| 分子式 | C22H18Cl2N8 |
| 分子量 | 465.34 |
| 外觀 | Off-white to light brown powder |
| 儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| 英文名稱 | Laduviglusib | CHIR-99021 | CT99021 |
|---|---|
| 中文名稱 | 拉格魯西布 |
| CAS號 | 252917-06-9 |
| 分子式 | C22H18Cl2N8 |
| 分子量 | 465.34 |
| 外觀 | Off-white to light brown powder |
| 儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| 化學(xué)穩(wěn)定性 | DMSO中的溶液可在-20°下穩(wěn)定儲存3個月。 |
|---|
Laduviglusib (CHIR-99021, CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively. CHIR99201 does not exhibit cross-reactivity against cyclin-dependent kinases (CDKs) and shows a 350-fold selectivity toward GSK-3β compared to CDKs. CHIR99021 functions as a Wnt/β-catenin activator and induces autophagy.